Lenalidomide, Bortezomib, and Dexamethasone (Rev/Vel/Dex) in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Preliminary Results of a Phase II Study.
暂无分享，去创建一个
D. Esseltine | S. Jagannath | A. Jakubowiak | S. Lonial | N. Munshi | P. Richardson | C. Mitsiades | N. Raje | T. Hideshima | I. Ghobrial | R. Schlossman | R. Knight | A. Mazumder | M. McKenney | K. Colson | K. Anderson | L. Lunde | M. Farrell | Lawrence Giove | S. Kaster